The Breast Journal (Jan 2024)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer

  • Miaomiao Jia,
  • Haibo Yang,
  • Lihui Pan,
  • Jinnan Gao,
  • Fan Guo

DOI
https://doi.org/10.1155/2024/8851703
Journal volume & issue
Vol. 2024

Abstract

Read online

Conclusion: HER2 IHC 2+ may indicate a decreased tpCR rate, bpCR rate, and apCR rate to neoadjuvant treatment in HR-positive patients having HER2-positive breast cancer, but not in HR-negative patients.